← back to search

Zvi Granot

Hebrew University of Jerusalem · IL
Area of research
Immunology · Oncology
Research interest
Research interests include Biology, Immunology, Cancer research, Immune system, Cancer, and Tumor microenvironment.
h-index
citations
4,662
works
42
NIH funding
primary concept
email

Recent publications

From complexity to consensus: A roadmap for neutrophil classification
Immunity 2025cited by 25position: middledoi
Neutrophil-specific targeting of STAT3 impairs tumor progression via the expansion of cytotoxic CD8+ T cells
Signal Transduction and Targeted Therapy 2025cited by 5position: middledoi
γδ T Cell‐mediated Tumor Immunity is Tightly Regulated by STING and TGF‐β Signaling Pathways
Advanced Science 2024cited by 16position: middledoi
Neutrophils in the tumor microenvironment – when a company becomes a crowd
Cellular and Molecular Immunology 2024cited by 13position: lastdoi
A comprehensively prognostic and immunological analysis of PARP11 in pan-cancer
Journal of Leukocyte Biology 2024cited by 6position: middledoi
IRE1 endoribonuclease signaling promotes myeloid cell infiltration in glioblastoma
Neuro-Oncology 2023cited by 18position: middledoi
Neutrophil phenotypes and functions in cancer: A consensus statement
The Journal of Experimental Medicine 2022cited by 341position: middledoi
Neutrophils impose strong immune pressure against PfEMP1 variants implicated in cerebral malaria
EMBO Reports 2022cited by 34position: lastdoi
ICAM-1 on Breast Cancer Cells Suppresses Lung Metastasis but Is Dispensable for Tumor Growth and Killing by Cytotoxic T Cells
Frontiers in Immunology 2022cited by 21position: middledoi
Targeted nanoparticles modify neutrophil function in vivo
Frontiers in Immunology 2022cited by 21position: lastdoi
Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance
Genome Medicine 2022cited by 18position: middledoi
Asymmetric inheritance of RNA toxicity in C. elegans expressing CTG repeats
iScience 2022cited by 3position: middledoi
Radiation sparks a dark side in neutrophils
Nature Cancer 2022cited by 3position: lastdoi
The PD-L1/PD-1 Axis Blocks Neutrophil Cytotoxicity in Cancer
Cells 2021cited by 75position: lastdoi
The inhibitory receptor CD300a is essential for neutrophil‐mediated clearance of urinary tract infection in mice
European Journal of Immunology 2021cited by 9position: middledoi
Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression
Nature Communications 2020cited by 691position: middledoi
Interleukin-1α dependent survival of cardiac fibroblasts is associated with StAR/STARD1 expression and improved cardiac remodeling and function after myocardial infarction
Journal of Molecular and Cellular Cardiology 2020cited by 8position: middledoi
Immature Low-Density Neutrophils Exhibit Metabolic Flexibility that Facilitates Breast Cancer Liver Metastasis
Cell Reports 2019cited by 247position: middledoi
Neutrophil Cathepsin G and Tumor Cell RAGE Facilitate Neutrophil Anti-Tumor Cytotoxicity
OncoImmunology 2019cited by 63position: lastdoi
Targeted siRNA Nanoparticles for Mammary Carcinoma Therapy
Cancers 2019cited by 20position: middledoi
TRPM2 Mediates Neutrophil Killing of Disseminated Tumor Cells
Cancer Research 2018cited by 228position: lastdoi
TRPM2 modulates neutrophil attraction to murine tumor cells by regulating CXCL2 expression
Cancer Immunology Immunotherapy 2018cited by 49position: lastdoi
Microenvironmental Cues Determine Tumor Cell Susceptibility to Neutrophil Cytotoxicity
Cancer Research 2018cited by 33position: lastdoi
Hyperglycemia Impairs Neutrophil Mobilization Leading to Enhanced Metastatic Seeding
Cell Reports 2017cited by 53position: lastdoi
Stromal Cell-Derived Factor 1 Mediates Immune Cell Attraction upon Urinary Tract Infection
Cell Reports 2017cited by 45position: middledoi
Polymeric nanoparticles of siRNA prepared by a double-emulsion solvent-diffusion technique: Physicochemical properties, toxicity, biodistribution and efficacy in a mammary carcinoma mice model
Biomaterials 2017cited by 35position: middledoi
Always Look On the Bright Side: Anti-Tumor Functions of Neutrophils
Current Pharmaceutical Design 2017cited by 27position: lastdoi
Isolation and Characterization of Low- vs. High-Density Neutrophils in Cancer
Methods in molecular biology 2016cited by 40position: lastdoi
Macrophages and Neutrophils: Regulation of the Inflammatory Microenvironment in Autoimmunity and Cancer
Mediators of Inflammation 2016cited by 25position: middledoi
Phenotypic Diversity and Plasticity in Circulating Neutrophil Subpopulations in Cancer
Cell Reports 2015cited by 816position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Zvi G. Fridlender · Hebrew University of Jerusalem12 papers (2014–2024)Ronit Vogt Sionov · Hebrew University of Jerusalem10 papers (2014–2019)Tanya Fainsod-Levi · Hebrew University of Jerusalem7 papers (2017–2021)Maya Gershkovitz · Hebrew University of Jerusalem6 papers (2015–2018)Jitka Yehudith Sagiv · Hebrew University of Jerusalem5 papers (2015–2017)Lola Polyansky · Hebrew University of Jerusalem5 papers (2015–2019)Olga Yajuk · Hebrew University of Jerusalem4 papers (2020–2022)Ofer Mandelboim · Hebrew University of Jerusalem4 papers (2013–2021)Tamir Zelter · Hebrew University of Jerusalem4 papers (2018–2022)Sandra Völs · Hebrew University of Jerusalem4 papers (2017–2022)Gilad Bachrach · Hebrew University of Jerusalem4 papers (2013–2021)Inbal Mishalian · Hebrew University of Jerusalem4 papers (2014–2015)Meital Ben-David-Naim · Hebrew University of Jerusalem3 papers (2017–2022)Batya Isaacson · Hebrew University of Jerusalem3 papers (2017–2021)Merav E. Shaul · Hebrew University of Jerusalem3 papers (2018–2022) · 3 papers (2014–2018)Benjamin Gläser · Hebrew University of Jerusalem3 papers (2012–2015)Saleh Khawaled · Hebrew University of Jerusalem3 papers (2017–2018)Yuval Dor · Ludwig-Maximilians-Universität München3 papers (2012–2015)Simaan Assi · Hebrew University of Jerusalem3 papers (2015–2015)